Latest Issue
Get instant access to latest e-book

LATEST NEWSRead more...

20

Jul 2019

Janssen Seeks EMA Approval for Novel Subcutaneous Formulation of DARZALEX (daratumumab)

The Janssen Pharmaceutical Companies of Johnson Johnson today announced the submission of an extension application to the European Medicines Agency EMA for subcutaneous under the skin use of DARZALEX daratumumab for the treatment of patients with multiple myeloma This subcutaneous formulation of da...

19

Jul 2019

Boehringer Ingelheim Expands Idiopathic Pulmonary Fibrosis (IPF) Pipeline Through Collaboration and License Agreement with Bridge Biotherapeutics

Boehringer Ingelheim and Bridge Biotherapeutics Inc today announced that they are entering into a new collaboration and license agreement with the goal of developing Bridge Biotherapeuticss autotaxin inhibitor BBT for patients with fibrosing interstitial lung diseases including IPF BBT is currently...

19

Jul 2019

Mallinckrodt And Silence Therapeutics Announce Collaboration To Develop And Commercialize RNAi Therapeutics For Complement-Mediated Diseases

Mallinckrodt plc a global biopharmaceutical company and Silence Therapeutics plc a leader in the discovery development and delivery of novel RNA interference RNAi therapeutics for the treatment of serious diseases today announced a collaboration that will allow the companies to develop and commerci...

18

Jul 2019

Anixa Biosciences Announces a Strategic Alliance and Licensing Agreement with Cleveland Clinic for an Innovative Breast Cancer Vaccine Technology

Anixa Biosciences Inc a biotechnology company focused on harnessing the bodys immune system to fight cancer today announced that it has established a strategic alliance and license agreement with Cleveland Clinic for an innovative breast cancer vaccine technology

18

Jul 2019

PureTech Acquires New Clinical-Stage Program LYT-100 to Treat Lymphedema

PureTech Health plc an advanced biopharmaceutical company developing novel medicines for dysfunctions of the BrainImmuneGut BIG axis today announced it has acquired and plans to develop a clinicalstage product candidate for the potential treatment of lymphatic and immunofibrotic diseases including l...

press releasesRead more...

20

Jul 2019

Transgene receives approval to start clinical trial of TG6002 in UK patients with colorectal cancer with liver metastases

Transgene Paris TNG a biotechnology company that designs and develops immunotherapies based on viral vectors against cancer announces that it has received approval from the UK health authority the Medicines and Healthcare Products Regulatory Agency MHRA to conduct a Phase a clinical trial of TG a...

19

Jul 2019

Pear Therapeutics Announces FDA Submission for Somryst™, a Prescription Digital Therapeutic for the Treatment of Adults with Chronic Insomnia and Depression

Pear Therapeutics today announced the filing of a submission to the US Food and Drug Administration FDA seeking marketing authorization for Somryst a prescription digital therapeutic PDT intended for use in the treatment of adults with chronic insomnia and depression Depression is the most common co...

19

Jul 2019

Spring Bank Announces Research Agreement with The National Institute of Allergy and Infectious Diseases to Evaluate HBV Antisense Oligonucleotide Compounds

Spring Bank Pharmaceuticals Inc a clinicalstage biopharmaceutical company developing novel therapeutics for the treatment of viral infections inflammatory diseases and certain cancers today announced that it has entered into a research agreement with The National Institute of Allergy and Infectious...

18

Jul 2019

Jet milling industrialization of sticky active pharmaceutical ingredient using quality-by-design approach

FPS has recently cooperated with pharmaceutical industry experts in a research on jet mills practices in pharmaceutical industries FPS sincerely believes on sharing and constant improvement at all levels For this reason the President Eng Gianola and the Vice President Mr Corsini both experts in mill...

18

Jul 2019

AUM Biosciences Expands Pipeline With Global License for First-in-class Targeted Cancer Therapy

AUM Biosciences AUM an awardwinning company focused on the development of innovative and affordable oncology medicines with high unmet medical need in Asia today announced a global license agreement with Inflection Biosciences Inflection for exclusive worldwide rights to develop manufacture and comm...

EventsRead more...

19 - 20

Jul 2019

7th World Heart Congress

Heart Conferences
Vienna

24 - 25

Jul 2019

24 - 25

Jul 2019

Dementia and Dementia Care

Holiday Inn Rome Aurelia Via Aurelia

25 - 26

Jul 2019

Advertisements

Rousselot - X-PURE®

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshoot...

EDITORIAL SECTION